Gout and risk of Parkinson disease: a prospective study - PubMed (original) (raw)
Gout and risk of Parkinson disease: a prospective study
Alvaro Alonso et al. Neurology. 2007.
Abstract
Background: Several reports suggest that higher levels of serum uric acid are associated with a lower risk of Parkinson disease (PD). None of these studies, however, evaluated the potential association between gout, a condition characterized by hyperuricemia, and the risk of PD.
Objective: To estimate prospectively the association between gout diagnosis and the risk of PD.
Methods: We conducted a case-control study nested in the General Practice Research Database, a computerized database that gathers information on more than 3 million Britons followed up by their general practitioners. PD cases occurring between January 1995 and December 2001 were identified, and matched with up to 10 controls by sex, age, practice, and start of follow-up. We obtained information on history of gout and use of anti-gout medication using the computerized medical records.
Results: During the study period, we identified 1,052 PD cases and 6,634 controls. Individuals with previous history of gout had a lower risk of developing PD (OR 0.69, 95% CI 0.48, 0.99). This association was evident among men (OR 0.60, 95% CI 0.40, 0.91) but not among women (OR 1.26, 95% CI 0.57, 2.81; p for interaction: 0.11). Initiation of anti-gout medication was associated with a lower risk of PD (OR 0.57, 95% CI 0.19, 1.70).
Conclusion: Gout is associated with a lower risk of Parkinson disease (PD). Our findings provide additional support for a potential link between uric acid and PD. Further research is required to explore a potential effect modification by sex.
Comment in
- Re: Gout and risk of Parkinson disease: a prospective study.
Iwasaki Y, Kano O, Ikeda K. Iwasaki Y, et al. Neurology. 2008 Jul 1;71(1):70; author reply 70. doi: 10.1212/01.wnl.0000319143.66421.2b. Neurology. 2008. PMID: 18591512 No abstract available. - Re: Gout and risk of Parkinson disease: a prospective study.
Schlesinger I, Schlesinger N. Schlesinger I, et al. Neurology. 2008 Jul 1;71(1):70; author reply 70. Neurology. 2008. PMID: 18598007 No abstract available.
Similar articles
- Gout and the risk of Parkinson's disease: a cohort study.
De Vera M, Rahman MM, Rankin J, Kopec J, Gao X, Choi H. De Vera M, et al. Arthritis Rheum. 2008 Nov 15;59(11):1549-54. doi: 10.1002/art.24193. Arthritis Rheum. 2008. PMID: 18975349 - Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
Pakpoor J, Seminog OO, Ramagopalan SV, Goldacre MJ. Pakpoor J, et al. BMC Neurol. 2015 Feb 28;15:16. doi: 10.1186/s12883-015-0273-9. BMC Neurol. 2015. PMID: 25884318 Free PMC article. - Risk of Parkinson's disease in a gout Mediterranean population: A case-control study.
Pou MA, Orfila F, Pagonabarraga J, Ferrer-Moret S, Corominas H, Diaz-Torne C. Pou MA, et al. Joint Bone Spine. 2022 Nov;89(6):105402. doi: 10.1016/j.jbspin.2022.105402. Epub 2022 Apr 30. Joint Bone Spine. 2022. PMID: 35504516 - Gout, hyperuricemia, and Parkinson's disease: a protective effect?
Alonso A, Sovell KA. Alonso A, et al. Curr Rheumatol Rep. 2010 Apr;12(2):149-55. doi: 10.1007/s11926-010-0083-4. Curr Rheumatol Rep. 2010. PMID: 20425025 Review. - Gout is not associated with a lower risk of Parkinson's disease: A systematic review and meta-analysis.
Ungprasert P, Srivali N, Thongprayoon C. Ungprasert P, et al. Parkinsonism Relat Disord. 2015 Oct;21(10):1238-42. doi: 10.1016/j.parkreldis.2015.08.030. Epub 2015 Aug 28. Parkinsonism Relat Disord. 2015. PMID: 26330027 Review.
Cited by
- Identification of Drugs Associated with Lower Risk of Parkinson's Disease Using a Systematic Screening Approach in a Nationwide Nested Case-Control Study.
Koponen M, Paakinaho A, Lin J, Hartikainen S, Tolppanen AM. Koponen M, et al. Clin Epidemiol. 2022 Oct 27;14:1217-1227. doi: 10.2147/CLEP.S381289. eCollection 2022. Clin Epidemiol. 2022. PMID: 36325200 Free PMC article. - Biological fluid biomarkers in neurodegenerative parkinsonism.
Eller M, Williams DR. Eller M, et al. Nat Rev Neurol. 2009 Oct;5(10):561-70. doi: 10.1038/nrneurol.2009.135. Epub 2009 Sep 1. Nat Rev Neurol. 2009. PMID: 19724250 Review. - Cypin: A novel target for traumatic brain injury.
Swiatkowski P, Sewell E, Sweet ES, Dickson S, Swanson RA, McEwan SA, Cuccolo N, McDonnell ME, Patel MV, Varghese N, Morrison B, Reitz AB, Meaney DF, Firestein BL. Swiatkowski P, et al. Neurobiol Dis. 2018 Nov;119:13-25. doi: 10.1016/j.nbd.2018.07.019. Epub 2018 Jul 19. Neurobiol Dis. 2018. PMID: 30031156 Free PMC article. - Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.
Hernán MA, Alonso A, Logan R, Grodstein F, Michels KB, Willett WC, Manson JE, Robins JM. Hernán MA, et al. Epidemiology. 2008 Nov;19(6):766-79. doi: 10.1097/EDE.0b013e3181875e61. Epidemiology. 2008. PMID: 18854702 Free PMC article. - Targets for neuroprotection in Parkinson's disease.
Yacoubian TA, Standaert DG. Yacoubian TA, et al. Biochim Biophys Acta. 2009 Jul;1792(7):676-87. doi: 10.1016/j.bbadis.2008.09.009. Epub 2008 Oct 1. Biochim Biophys Acta. 2009. PMID: 18930814 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical